Showing results (1-10 of 317) with videos related to
Sort By:
Pageof 32
Frontiers in Pharmacology|October 29, 2024
Multiple mechanisms enable broad-spectrum activity of the Pelargonium sidoides root extract EPs 7630 against acute respiratory tract infectionsJindrich Cinatl, Mark N Wass, Martin MichaelisCancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Drug-adapted cancer cell lines as preclinical models of acquired resistanceMartin Michaelis, Mark N Wass, Jindrich CinatlBeilstein Journal of Nanotechnology|November 16, 2019
Incorporation of doxorubicin in different polymer nanoparticles and their anticancer activitySebastian Pieper, Hannah Onafuye, Dennis Mulac, et al.Beilstein Journal of Nanotechnology|September 11, 2019
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cellsHannah Onafuye, Sebastian Pieper, Dennis Mulac, et al.Frontiers in Microbiology|December 19, 2019
Omeprazole Increases the Efficacy of Acyclovir Against Herpes Simplex Virus Type 1 and 2Martin Michaelis, Malte C Kleinschmidt, Denisa Bojkova, et al.BMC Research Notes|June 25, 2014
Effects of flavonoid-induced oxidative stress on anti-H5N1 influenza a virus activity exerted by baicalein and biochanin AMartin Michaelis, Patchima Sithisarn, Jindrich CinatlChemmedchem|December 13, 2019
Thiourea and Guanidine Compounds and Their Iridium Complexes in Drug-Resistant Cancer Cell Lines: Structure-Activity Relationships and Direct Luminescent ImagingSamuel J Thomas, Barbora Balónová, Jindrich Cinatl, et al.Diagnostics (Basel, Switzerland)|August 6, 2020
COVID-19-Related Coagulopathy-Is Transferrin a Missing Link?Katie-May McLaughlin, Marco Bechtel, Denisa Bojkova, et al.FEBS Open Bio|June 26, 2025
Phenotypic plasticity in a novel set of EGFR tyrosine kinase inhibitor-adapted non-small cell lung cancer cell linesTharsagini V Nanthaprakash, Campbell W Gourlay, Ina Oehme, et al.Medical Microbiology and Immunology|April 5, 2007
The threat of avian influenza a (H5N1): part II: Clues to pathogenicity and pathologyJindrich Cinatl, Martin Michaelis, Hans W DoerrPageof 32